A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2011
10/19/2011	CN102219908A Completely-biodegraded nanometer starch grafted poly glutamic acid benzyl ester
10/19/2011	CN102219860A FGFR-Fc fusion protein and applications thereof
10/19/2011	CN102219850A New long-acting GLP-1 (glucagonlike peptide-1) compounds
10/19/2011	CN102218150A Novel liver-targeting nanometer Fe3O4MRI (Magnetic Resonance Imaging) contrast medium and preparation method
10/19/2011	CN102218148A Use of epstein-barr virus miR-BART1-5p antisense oligonucleotide in preparing drugs for treating nasopharyngeal carcinoma
10/19/2011	CN102218147A Use of epstein-barr virus miR-BART7 antisense oligonucleotide in preparing drugs for treating nasopharyngeal carcinoma
10/19/2011	CN102218143A Water dispersion type carbon nano-tube freeze-dried powder and preparation method thereof
10/19/2011	CN102218129A New drug delivery system of gynaecologic panchrest plaster
10/19/2011	CN102218092A Dispersion tablets of traditional Chinese medicine composition
10/19/2011	CN102218079A Biological colloid dispersant used for wound-protection and its preparation method
10/19/2011	CN102218059A Aztreonam-compound-containing composition
10/19/2011	CN102218046A Chinese patent medicine soft capsule ingredients-mixing technology
10/19/2011	CN102218045A New glue dissolving technology of soft capsules
10/19/2011	CN102218043A LDH (Layered Double Hydroxides) supermolecular assembly type aspirin sustained release tablet and preparation method thereof
10/19/2011	CN102218042A Sustained release tablet of quetiapine fumarate composition and preparation method of sustained release tablet
10/19/2011	CN102218041A Ebastine solid dispersion and high-dissolubility ebastine tablet prepared by the same
10/19/2011	CN102218040A Oral disintegrating tablets of microcrystallites of aripiprazole composition and preparation method thereof
10/19/2011	CN102218039A Formula, preparation method and use of potassium sodium dehydroandroan drographolide succinate liposome combined medicament
10/19/2011	CN102218038A Formula, preparation method and application of tolazoline hydrochloride liposome combination medicine
10/19/2011	CN102218037A Ifosfamide liposome combination medicament, and formula, preparation method and purpose thereof
10/19/2011	CN102218036A Formula, preparation method and application of omeprazole sodium liposome composite medicament
10/19/2011	CN102218035A Formula of combined medicament of esomeprazole sodium liposomes, method for preparing same and application thereof
10/19/2011	CN102218034A Formula, preparation method and use of azithromycin liposome combined medicament
10/19/2011	CN102218033A Formula, preparation method and use of alprostadil liposome combined medicament
10/19/2011	CN102218032A Formula, preparation method and application of lansoprazole liposome composite medicament
10/19/2011	CN102218031A Formula, preparation method and use of lactose-azithromycin liposome combined medicine
10/19/2011	CN102218030A Formula, preparation method and application of pantoprazole sodium liposome composite medicament
10/19/2011	CN102218029A Formula, preparation method and use of pefloxacin mesylate liposome combined medicament
10/19/2011	CN102218027A Polymer micelle lyophilized agent encapsulating insoluble antitumor drug
10/19/2011	CN102217757A Plant superoxide dismutase buccal tablets and preparation method thereof
10/19/2011	CN102028662B Levamlodipine besylate tablet, preparation process thereof and control method for relevant materials
10/19/2011	CN101926774B Azithromycin powder composite and preparation method thereof
10/19/2011	CN101849916B Cefpiramide sodium powder injection and preparation method thereof
10/19/2011	CN101785782B Long-circulating ligustrazine composite injection and preparation method thereof
10/19/2011	CN101785766B Lidocaine and chlorhexidine aerosol
10/19/2011	CN101756912B Hemocoagulase freeze-dried powder injection and preparation method thereof
10/19/2011	CN101703469B Preparation method and products of danofloxacin mesylate liposome
10/19/2011	CN101700257B Pomegranate peel polyphenol antibiosis and antiphlogosis effervescent tablet as well as preparation method and application thereof
10/19/2011	CN101695476B Method for preparing medical nanoparticles
10/19/2011	CN101574413B Traditional Chinese medicine preparation for curing rheumatoid arthritis and preparation method thereof
10/19/2011	CN101573300B Hydrogen-dissolved aqueous solution and method for prolonging the life duration of hydrogen dissolved in the aqueous solution
10/19/2011	CN101554366B Method for preparing carboxymethyl chitose gel applicable to site-specific delivery drugs in gastrointestinal tract
10/19/2011	CN101528215B Compositions of chk1 inhibitors and cyclodextrin
10/19/2011	CN101474150B Stable alprostadil injection emulsion and preparation method thereof
10/19/2011	CN101255235B Thermo-sensitive tri-block copolymer having sol-gel conversion characteristic and preparation thereof
10/19/2011	CN101167749B Preparing method for improving toad venom taste
10/19/2011	CN101152147B Ligustrazine compound emulsion and method for preparing the same
10/18/2011	US8039579 Intermediates useful in the preparation of maleimide functionalized polymers
10/18/2011	US8039508 Obesity therapy; mixture of lipase inhibitor orlistat and sucrose fatty acid ester
10/18/2011	US8039482 Composition of solifenacin or salt thereof for use in solid formulation
10/18/2011	US8039452 Antifungal medicinal compositions
10/18/2011	US8039444 Antisense permeation enhancers
10/18/2011	US8039259 Buffer solution for electroporation and a method comprising the use of the same
10/18/2011	US8039010 Glycolic acid-lactic acid copolymer; biocompatible; biodegradable; RNA interference; inhibitors of vascular endothelial growth factor (VEGF); ocular disorders
10/18/2011	US8039006 Solid composition containing bacillus-type non-pathogenic bacterial spores
10/18/2011	US8039000 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer
10/18/2011	US8038983 Fluorinated carbohydrate conjugates
10/18/2011	CA2515663C Chitosan-based transport system
10/18/2011	CA2494541C Shiga toxin b-subunit as a vector for tumor diagnosis and drug delivery to gb3 expressing tumors
10/18/2011	CA2494297C Aqueous 2,6-diisopropylphenol pharmaceutical compositions
10/18/2011	CA2487123C Patch containing fentanyl
10/18/2011	CA2470643C Cleavable reagents for specific delivery to disease sites
10/18/2011	CA2464653C System for manufacturing controlled release dosage forms, such as a zero-order release profile dosage form manufactured by three-dimensional printing
10/18/2011	CA2462345C Dimeric compounds and their use as anti-viral agents
10/18/2011	CA2456286C Porous matrix comprising cross-linked particles
10/18/2011	CA2453441C Lyophilizing composition of drug-encapsulating polymer micelle and method for preparation thereof
10/18/2011	CA2434927C Pharmaceutical compositions with antibiotic activity
10/18/2011	CA2419842C New aporphine esters and their use in therapy
10/18/2011	CA2413692C Method of making particles for use in a pharmaceutical composition
10/18/2011	CA2372099C Antiviral agent in the form of nose drops
10/18/2011	CA2337328C Biocompatible polymers, preparation method and compositions containing same
10/18/2011	CA2228944C Liposomal phosphodiester, phosphorothioate, and p-ethoxy oligonucleotides
10/18/2011	CA2226575C Stabile isotonic lyophilized protein formulation
10/14/2011	CA2736998A1 A composition
10/13/2011	WO2011127405A1 Methods and compositions for enhanced delivery of compounds
10/13/2011	WO2011127252A2 Miniature ingestible device
10/13/2011	WO2011127179A1 Glycomimetic compounds and methods to inhibit infection by hiv
10/13/2011	WO2011127090A1 Conditioned medium obtained form stem cells and its use in therapy
10/13/2011	WO2011127061A1 Enhancement of radiation therapy by targeted high-z nanoparticles
10/13/2011	WO2011126839A2 Compositions and methods for improved retention of a pharmaceutical composition at a local administration site
10/13/2011	WO2011126537A2 Oral adhering compositions that apply rhizophora mangle extract in the mouth
10/13/2011	WO2011126352A2 Anti-tuberculosis preparation based on an inclusion complex of cyclodextrin with rifampicin and a method for the preparation thereof
10/13/2011	WO2011126327A2 Pharmaceutical composition with controlled-release properties comprising mosapride or levodropropizine, and preparing method thereof
10/13/2011	WO2011126010A1 Cancer cell-specific cell-penetrating peptide and use thereof
10/13/2011	WO2011125943A1 Modified oligonucleotide
10/13/2011	WO2011125910A1 Calcium preparation and production method therefor
10/13/2011	WO2011125848A1 Production method for liposome preparation
10/13/2011	WO2011125798A1 Easily dosable solid preparation
10/13/2011	WO2011125607A1 Method for manufacturing hydrophilic polymer-modified liposomes
10/13/2011	WO2011125500A1 Process for producing granules of fine particles containing sparingly water-soluble drug
10/13/2011	WO2011125331A1 Metal salen complex derivative and process for production thereof
10/13/2011	WO2011125091A1 Edible film
10/13/2011	WO2011125015A2 Protease-activatable pore-forming polypeptides
10/13/2011	WO2011124973A1 Excipient from trigonella foenum-graceum seeds and process for preparation thereof
10/13/2011	WO2011124899A1 Cell poration
10/13/2011	WO2011124739A1 Silica nanoparticles for the intracellular diffusion of poorly soluble bioactive agents
10/13/2011	WO2011124570A2 Oral film formulation
10/13/2011	WO2011123957A1 Biocompatible poly(amic acid) and method of preparation thereof
10/13/2011	WO2011089250A3 Stable growth hormone compounds
10/13/2011	WO2011073222A3 Hyperbranched polyester having a hydrophobic core for solubilizing active ingredients of low solubility

1 ... 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 ... 1712